chr1-59909816-A-C
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_000775.4(CYP2J2):c.829T>G(p.Phe277Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000104 in 1,444,858 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000010 ( 0 hom. )
Consequence
CYP2J2
NM_000775.4 missense
NM_000775.4 missense
Scores
5
12
1
Clinical Significance
Conservation
PhyloP100: 7.14
Publications
0 publications found
Genes affected
CYP2J2 (HGNC:2634): (cytochrome P450 family 2 subfamily J member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is thought to be the predominant enzyme responsible for epoxidation of endogenous arachidonic acid in cardiac tissue. Multiple transcript variants have been found for this gene. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000775.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYP2J2 | TSL:1 MANE Select | c.829T>G | p.Phe277Val | missense | Exon 5 of 9 | ENSP00000360247.3 | P51589 | ||
| CYP2J2 | c.820T>G | p.Phe274Val | missense | Exon 5 of 9 | ENSP00000575966.1 | ||||
| CYP2J2 | c.829T>G | p.Phe277Val | missense | Exon 5 of 9 | ENSP00000575969.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.0000104 AC: 15AN: 1444858Hom.: 0 Cov.: 30 AF XY: 0.0000125 AC XY: 9AN XY: 718304 show subpopulations
GnomAD4 exome
AF:
AC:
15
AN:
1444858
Hom.:
Cov.:
30
AF XY:
AC XY:
9
AN XY:
718304
show subpopulations
African (AFR)
AF:
AC:
11
AN:
31968
American (AMR)
AF:
AC:
0
AN:
39800
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25626
East Asian (EAS)
AF:
AC:
0
AN:
39136
South Asian (SAS)
AF:
AC:
0
AN:
82038
European-Finnish (FIN)
AF:
AC:
0
AN:
53294
Middle Eastern (MID)
AF:
AC:
0
AN:
5720
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1107544
Other (OTH)
AF:
AC:
4
AN:
59732
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Uncertain
D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Loss of catalytic residue at F277 (P = 0.0885)
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.